Nutex Health, Inc. (NUTX)
NUTX Stock Price Chart
Explore Nutex Health, Inc. interactive price chart. Choose custom timeframes to analyze NUTX price movements and trends.
NUTX Company Profile
Discover essential business fundamentals and corporate details for Nutex Health, Inc. (NUTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
4 Apr 2022
Employees
800.00
Website
https://www.nutexhealth.comCEO
Thomas T. Vo
Description
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
NUTX Financial Timeline
Browse a chronological timeline of Nutex Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Nov 2026
EPS estimate is $5.26, while revenue estimate is $218.96m.
Upcoming earnings on 30 Jul 2026
EPS estimate is $4.95, while revenue estimate is $215.03m.
Earnings released on 30 Apr 2026
EPS came in at $6.52 surpassing the estimated $3.99 by +63.41%, while revenue for the quarter reached $216.49m , missing expectations by -4.97%.
Earnings released on 5 Mar 2026
EPS came in at $1.61 falling short of the estimated $5.56 by -71.04%, while revenue for the quarter reached $151.70m , missing expectations by -41.39%.
Earnings released on 19 Nov 2025
EPS came in at $7.76 surpassing the estimated $1.81 by +328.73%, while revenue for the quarter reached $267.80m , beating expectations by +25.25%.
Earnings released on 22 Oct 2025
EPS came in at -$2.95 falling short of the estimated -$1.43 by -105.81%, while revenue for the quarter reached $243.99m , missing expectations by -0.01%.
Earnings released on 13 May 2025
EPS came in at $2.56 falling short of the estimated $3.04 by -15.79%, while revenue for the quarter reached $211.79m , beating expectations by +57.77%.
Earnings released on 31 Mar 2025
EPS came in at $11.12 surpassing the estimated -$0.12 by +9.37k%, while revenue for the quarter reached $257.62m , beating expectations by +217.56%.
Earnings released on 8 Nov 2024
EPS came in at -$1.72 falling short of the estimated -$0.24 by -616.67%, while revenue for the quarter reached $78.79m , beating expectations by +7.61%.
Earnings released on 8 Aug 2024
EPS came in at -$0.07 surpassing the estimated -$0.29 by +75.86%, while revenue for the quarter reached $76.08m , beating expectations by +11.56%.
Stock split effective on 3 Jul 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 May 2024
EPS came in at -$0.10 , while revenue for the quarter reached $67.45m , missing expectations by 0.00%.
Stock split effective on 10 Apr 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Mar 2024
EPS came in at -$7.50 , while revenue for the quarter reached $69.67m , missing expectations by -2.42%.
Earnings released on 9 Nov 2023
EPS came in at -$1.50 matching the estimated -$1.50, while revenue for the quarter reached $62.72m , missing expectations by -6.19%.
Earnings released on 9 Aug 2023
EPS came in at -$1.50 matching the estimated -$1.50, while revenue for the quarter reached $58.92m , missing expectations by -6.84%.
Earnings released on 15 May 2023
EPS came in at -$1.50 surpassing the estimated -$3.00 by +50.00%, while revenue for the quarter reached $56.33m , missing expectations by -9.22%.
Earnings released on 2 Mar 2023
EPS came in at -$3.00 matching the estimated -$3.00, while revenue for the quarter reached $53.72m , beating expectations by +7.56%.
Earnings released on 21 Nov 2022
EPS came in at -$3.00 , while revenue for the quarter reached $28.40m .
Earnings released on 22 Aug 2022
EPS came in at -$4.50 , while revenue for the quarter reached $58.05m .
Earnings released on 13 May 2022
EPS came in at $5.43 , while revenue for the quarter reached $79.13m .
Earnings released on 1 Apr 2022
EPS came in at $3.54 , while revenue for the quarter reached $63.40m .
Earnings released on 15 Nov 2021
EPS came in at $13.61 , while revenue for the quarter reached $117.97m .
Earnings released on 16 Aug 2021
EPS came in at $6.85 , while revenue for the quarter reached $62.81m .
NUTX Stock Performance
Access detailed NUTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
